Literature DB >> 21867676

AMP-activated protein kinase modulates the gene expression of aquaporin 9 via forkhead box a2.

Yuichi Yokoyama1, Kazuhiro Iguchi, Shigeyuki Usui, Kazuyuki Hirano.   

Abstract

Aquaporin 9 (AQP9) is permeable to glycerol, which is a source material in lipogenesis and gluconeogenesis in the liver. We investigated the transcriptional regulation of the AQP9 gene by AMP-activated protein kinase (AMPK), known as an energy sensor in cells since AMPK contributes to the metabolism of carbohydrate, lipid, and protein by regulating the expression of many enzymes and transcription factors in metabolic pathways. An AMPK activator, 5-aminoimidazole-4-carboxamide-1-β-d-ribonucleoside (AICAR), was observed to suppress the expression of the AQP9 gene in HepG2 cells by promoting the phosphorylation of AMPK and AKT/PKB. Forkhead box a2 (Foxa2) was speculated to be one of the transcriptional regulators of AQP9 gene expression repressed by AICAR from the results of a reporter gene assay with a plasmid containing the promoter region of the AQP9 gene and knock-down of the Foxa2 gene by a specific siRNA. AICAR was determined to induce the phosphorylation and nuclear exclusion of Foxa2. Leptomycin B, inhibiting the binding of the nuclear exclusion signal sequence and chromosome region maintenance 1, prevented nuclear export of Foxa2 triggered by AICAR. These results suggest that the activated AMPK by AICAR causes suppression of the gene expression of AQP9 through transcriptional regulation by Foxa2.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21867676     DOI: 10.1016/j.abb.2011.08.002

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Effects of metformin treatment on glioma-induced brain edema.

Authors:  Bin Zhao; Xiaoke Wang; Jun Zheng; Hailiang Wang; Jun Liu
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

2.  Analysis of aquaporin expression in liver with a focus on hepatocytes.

Authors:  Françoise Gregoire; Valério Lucidi; Amal Zerrad-Saadi; Myrna Virreira; Nargis Bolaky; Valérie Delforge; Arnaud Lemmers; Vincent Donckier; Jacques Devière; Pieter Demetter; Jason Perret; Christine Delporte
Journal:  Histochem Cell Biol       Date:  2015-07-01       Impact factor: 4.304

3.  A Systematic Characterization of Aquaporin-9 Expression in Human Normal and Pathological Tissues.

Authors:  Cecilia Lindskog; Anna Asplund; Anca Catrina; Søren Nielsen; Michael Rützler
Journal:  J Histochem Cytochem       Date:  2016-03-29       Impact factor: 2.479

4.  Treatment with AICAR inhibits blastocyst development, trophectoderm differentiation and tight junction formation and function in mice.

Authors:  Michele D Calder; Nicole A Edwards; Dean H Betts; Andrew J Watson
Journal:  Mol Hum Reprod       Date:  2017-11-01       Impact factor: 4.025

Review 5.  Hepatocyte and Sertoli Cell Aquaporins, Recent Advances and Research Trends.

Authors:  Raquel L Bernardino; Raul A Marinelli; Anna Maggio; Patrizia Gena; Ilaria Cataldo; Marco G Alves; Maria Svelto; Pedro F Oliveira; Giuseppe Calamita
Journal:  Int J Mol Sci       Date:  2016-07-09       Impact factor: 5.923

6.  Down-regulation of aquaporin 9 gene transcription by 10-hydroxy-2-decenoic acid: A major fatty acid in royal jelly.

Authors:  Shigeyuki Usui; Midori Soda; Kazuhiro Iguchi; Naohito Abe; Masayoshi Oyama; Tatsushi Nakayama; Kiyoyuki Kitaichi
Journal:  Food Sci Nutr       Date:  2019-10-21       Impact factor: 2.863

Review 7.  Sexual Dimorphism of Adipose and Hepatic Aquaglyceroporins in Health and Metabolic Disorders.

Authors:  Amaia Rodríguez; Raul A Marinelli; Angela Tesse; Gema Frühbeck; Giuseppe Calamita
Journal:  Front Endocrinol (Lausanne)       Date:  2015-11-05       Impact factor: 5.555

8.  Berberine and cinnamaldehyde together prevent lung carcinogenesis.

Authors:  Mingjing Meng; Shengnan Geng; Zhenhua Du; Jingjing Yao; Yaqiu Zheng; Zibo Li; Zhenzhen Zhang; Jiahuan Li; Yongjian Duan; Gangjun Du
Journal:  Oncotarget       Date:  2017-08-07

Review 9.  Aquaglyceroporins: Drug Targets for Metabolic Diseases?

Authors:  Giuseppe Calamita; Jason Perret; Christine Delporte
Journal:  Front Physiol       Date:  2018-07-10       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.